Meeting
2023 ASCO Genitourinary Cancers Symposium
Polo-like kinase-1 as a potential prognostic marker of prostate cancer utilizing ORIEN data.
Authors
Snigdha Nutalapati
University of Kentucky, Lexington, KY
Snigdha Nutalapati , Chi Wang , Alice X Liu , Zhuwei Zhang , Howard Colman , Elaine T. Lam , John D. Carpten , Eric A. Singer , Nabil Adra , Michael Edward Devitt , Jad Chahoud , Abhishek Tripathi , Kelly Lynn Stratton , Zin Myint
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 384)
DOI
10.1200/JCO.2023.41.6_suppl.384
Abstract #
384
Poster Bd #
P1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Prognostic biomarkers and clinical outcomes in neuroendocrine prostate cancer (NEPC).
First Author: Richard Gagnon
Poster
2024 ASCO Genitourinary Cancers Symposium
Impact of race on outcomes to 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC).
First Author: Avina Rami
Poster
2023 ASCO Genitourinary Cancers Symposium
RIPK2 as a prognostic biomarker and predictor of aggressive prostate cancer.
First Author: Mustafa Hammudi
Poster
2023 ASCO Genitourinary Cancers Symposium
Association between sociodemographic factors and diagnosis of advanced prostate cancer in early life.
First Author: Shayan Smani